BETA: Please send your feedback!
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$0
MEGA cap
$47.23
(-0.59%)
-0.00%
since start of 2020
20.12
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Major
Founded 1999
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
website
Headquarters
Executives
| Name | Title | Gender |
| Simon Dingemans | Chief Financial Officer & Executive Director | Male |
| Philip Roy Hampton, MBA | Non-Executive Chairman | Male |
| Dan Troy | Senior Vice President & General Counsel | Male |
| Patrick J. T. Vallance, MD | Executive Director, President-R&D | Male |
| Claire Thomas | Senior Vice President-Human Resources | Female |
| Emma Walmsley | Chief Executive Officer & Executive Director | Female |
| Ziba Shamsi | Head-Investor Relations | Female |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
GlaxoSmithKline - Competitors and Related Companies
How GlaxoSmithKline stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
$0
MEGA cap
$47.23
(-0.59%)
-0.00%
since start of 2020
20.12
AstraZeneca
AZN-GB:LON
Pharmaceuticals: Major
$129.30bn
MEGA cap
$49.28
(-0.92%)
-0.04%
since start of 2020
61.32
Novartis
NOVN-CH:SWX
Pharmaceuticals: Major
$18.11mm
MEGA cap
$0.68
(0.01%)
-0.78%
since start of 2020
-0.67
Pfizer
PFE:NYS
Pharmaceuticals: Major
$220.37bn
MEGA cap
$39.82
(-0.89%)
-0.01%
since start of 2020
13.68
GW Pharmaceuticals
GWPH:NAS
Pharmaceuticals: Other
$3.52bn
MID cap
$114.51
(-1.39%)
0.07%
since start of 2020
-59.27
Consort Medical
CSRT-GB:LON
Medical Specialties
—
SMALL cap
(—)
—
since start of 2020
—